ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $294 | -63.9% | 26,329 | +30.7% | 0.00% | -57.1% |
Q1 2023 | $815 | -99.9% | 20,147 | +57.3% | 0.01% | -22.2% |
Q3 2022 | $664,000 | +59.6% | 12,804 | +130.0% | 0.01% | +125.0% |
Q4 2021 | $416,000 | +44.4% | 5,568 | -11.5% | 0.00% | -33.3% |
Q3 2020 | $288,000 | – | 6,292 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |